Hong Kong Exchanges and Clearing (HKEX) to open an office in London on Wednesday in its latest push to attract more international listings and overseas investors.
SYDNEY : China's Sichuan Kelun-Biotech Pharmaceutical is looking to raise $208.6 million in a Hong Kong initial public offering, according to a term sheet seen by Reuters.The company is selling 22.44 million shares in a price range of HK$60.60 to HK$72.80 ($7.74-$9.30) each, the term sheet showed.T